Adult Vaccine Market will be US$ 35.87 Billion by 2032 compared to US$ 20.59 Billion in 2023
Global Adult Vaccine Market was US$ 20.59 Billion in 2023 and will grow US$ 35.87 Billion by 2032, with a CAGR of 6.36% from 2024 to 2032. Pneumococcal illness, influenza, COVID-19, and other diseases are becoming more common worldwide, which may increase demand for adult immunizations. Things like growing focus and awareness of healthcare Government and nonprofit immunization initiatives may potentially be the primary driver of market expansion.